Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 258 participants.
Also called NCT04924322
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 2/3
- Enrolled
- 258 participants
- Sponsor
- Registry
-
NCT04924322
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT04924322. Randomized; single masking; primary purpose prevention. Start 2022-05-11 (actual); primary completion 2027-04-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- Acronym
- CRETE
- Condition
- Deep Venous Thrombosis
- Intervention (Drug)
- Enoxaparin
- Lead sponsor
- Yale University
- Collaborator
- Children's Hospital Colorado
- Collaborator
- Children's Hospital of Philadelphia
- Collaborator
- BJC HealthCare
- Collaborator
- Medical College of Wisconsin
- Collaborator
- Children's of Alabama
- Collaborator
- Golisano Children's Hospital
- Collaborator
- Maria Fareri Children's Hospital
- Collaborator
- Nationwide Children's Hospital
- Collaborator
- New York Presbyterian Hospital
- Collaborator
- Penn State University
- Collaborator
- University of Iowa
- Collaborator
- Johns Hopkins All Children's Hospital
- Collaborator
- University of Oklahoma
- Collaborator
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Collaborator
- Children's Hospital of Illinois at Peoria
- Collaborator
- Hassenfeld Children's Hospital
Record details
- Record id
cardio:ct-nct04924322- Content hash
8a774cb23f0b791f7b209c05495dfc9f64763f38baabf9b9d5d21766b974c826